Literature DB >> 22119090

Serum adiponectin and resistin levels in patients with obsessive compulsive disorder.

Mustafa Ari1, Oktay Hasan Ozturk, Yasin Bez, Secil Arica, Yesim Can, Dudu Erduran.   

Abstract

We aimed to investigate the changes in serum adiponectin and resistin levels in patients with obsessive compulsive disorder and control groups. The serum adiponectin and resistin levels of 29 patients (16 females, 13 males) with obsessive compulsive disorder and weight, age and sex-matched 31 healthy controls (17 females, 14 males) were determined. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was applied to all groups. ELISA method was used to measure adiponectin and resistin levels. The mean adiponectin level was 11.92±2.04 ng/ml and resistin level was 13.23±2.78 ng/ml in obsessive compulsive disorder group, while it was 18.81±5.24 ng/ml and 8.17±2.53 ng/ml in control group. Changes in plasma adiponectin and resistin levels in obsessive compulsive disorder may have implications about possible cardiovascular and metabolic abnormalities seen in obsessive compulsive patients.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119090     DOI: 10.1016/j.jad.2011.07.029

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

Review 1.  Peptides from adipose tissue in mental disorders.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Maciej Pilecki; Barbara Kościelniak; Przemysław J Tomasik
Journal:  World J Psychiatry       Date:  2014-12-22

2.  Increased anxiety-like behavior is associated with the metabolic syndrome in non-stressed rats.

Authors:  Daniela Rebolledo-Solleiro; Gabriel Roldán-Roldán; Daniel Díaz; Myrian Velasco; Carlos Larqué; Guadalupe Rico-Rosillo; Gloria Bertha Vega-Robledo; Elena Zambrano; Marcia Hiriart; Miguel Pérez de la Mora
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

3.  Association between Obsessive-Compulsive Symptoms and Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: Effects of Depression Comorbidity and Treatment.

Authors:  Hee-Joon Lee; Ju-Wan Kim; Hee-Ju Kang; Sung-Wan Kim; Il-Seon Shin; Young-Joon Hong; Young-Keun Ahn; Myung-Ho Jeong; Jin-Sang Yoon; Jae-Min Kim
Journal:  Psychiatry Investig       Date:  2019-11-06       Impact factor: 2.505

4.  Comparison of Peripheral Biomarkers and Reduction of Stress Response in Patients With Major Depressive Disorders vs. Panic Disorder.

Authors:  Mi Jin Park; Eun Hye Jang; Ah Young Kim; Hyewon Kim; Hyun Soo Kim; Sangwon Byun; Han Young Yu; Hong Jin Jeon
Journal:  Front Psychiatry       Date:  2022-03-31       Impact factor: 4.157

5.  Plasma Apelin, Visfatin and Resistin Levels in Patients with First Episode Psychosis and Chronic Schizophrenia.

Authors:  Musa Sahpolat; Mustafa Ari; Mehmet Hanifi Kokacya
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.